Basket | Login

 
 
 
 

Clinical trials by country

Phase III trials

Bulgaria

  1. 17-AVP-786-305

Czech Republic

  1. 17-AVP-786-305

France

  1. CLARITY-AD
  2. LO-MAPT
  3. 17-AVP-786-305

Germany

  1. CLARITY-AD

Hungary

  1. 17-AVP-786-305

Italy

  1. CLARITY-AD
  2. 17-AVP-786-305

Netherlands

  1. ANAVEX®2-73-AD-004

Poland

  1. 17-AVP-786-305

Spain

  1. CLARITY-AD
  2. 17-AVP-786-305

Sweden

  1. CLARITY-AD

UK

  1. ANAVEX®2-73-AD-004
  2. CLARITY-AD
  3. NorAD
  4. 17-AVP-786-305

 

 
 

Last Updated: Friday 15 January 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options